Home/ Supplements/ Feverfew/ Feverfew 125 mg

Feverfew 125 mg

product on market Capsule Eclectic Herb Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for Feverfew 125 mg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
90
Servings
Botanical
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 380.0mg (120 products) 8 studies — no high-quality reviews

Other Ingredients

Hypromellose
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Use: Take 1 - 3 capsules per day.

Warnings & Precautions

Keep out of reach of children.

Discontinue use if unusual symptoms occur.

Consult your health care advisor regarding herbs with pregnancy, infants or prescription drugs.

Consult your health care advisor regarding herbs with pregnancy, infants or prescription drugs.

Formulation Notes

Antioxidant Whole Herbs

US Grown Raw Naturally Concentrated

Gluten free Non GMO

Vegan

Freeze Dried Fresh For Peak Plant Power Freeze-drying is the best method of preservation as it naturally concentrates the nutrients in the plant by removing only the water.

Nothing artificial - no fillers or additives.

Concentrated 3 1/2 X through freeze-drying

100% Kosher.

Additional Information

Our aronia berries are locally grown and fresh freeze-dried in-house in small batches.

@eclecticherb

Metadata

Product Details

UPC / SKU0 23363 30933 7
DSLD Entry Date2023-07-18
Product TypeBotanical
FormCapsule
DSLD ID294688
Data Updated2026-04-11
Research

Research Evidence

10
Research Sources
48
Avg Quality
4
Systematic Review
4
Rct
1
Meta Analysis
1
Cochrane Review
B Feverfew for preventing migraine.
Cochrane Review The Cochrane database of systematic reviews PubMed
C Feverfew for preventing migraine
Systematic Review The Cochrane database of systematic reviews 2004 PubMed
C Feverfew for preventing migraine
Systematic Review The Cochrane database of systematic reviews 2000 PubMed
C Randomised double-blind placebo-controlled trial of feverfew in migraine prevention
Rct Lancet (London, England) 1988 PubMed
C Feverfew for migraine prophylaxis: a systematic review
Systematic Review Journal of dietary supplements 2009 PubMed DOI
C Tanacetum parthenium and Salix alba (Mig-RL) combination in migraine prophylaxis: a prospective, open-label study
Meta Analysis Clinical drug investigation 2006 PubMed
C The combined effect of acupuncture and Tanacetum parthenium on quality of life in women with headache: randomised study
Rct Acupuncture in medicine : journal of the British Medical Acupuncture Society 2012 PubMed DOI
C A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial
Rct Headache 2004 PubMed
C Feverfew as a preventive treatment for migraine: a systematic review
Systematic Review Cephalalgia : an international journal of headache 1998 PubMed
D Efficacy of feverfew as prophylactic treatment of migraine
Rct British medical journal (Clinical research ed.) 1985 PubMed
View all evidence for Feverfew →
Compare

Similar Products

View all Feverfew products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.